product summary
Loading...
company name :
OriGene
product type :
other
product name :
PIK3C2G Human qPCR Primer Pair (NM_004570)
catalog :
HP207864
quantity :
200 reactions
price :
142 USD
more info or order :
product information
SKU :
HP207864
Category :
Gene Expression
Sub-Category :
qPCR Primer Pairs
Name :
PIK3C2G Human qPCR Primer Pair (NM_004570)
Description :
qSTAR qPCR primer pairs against Homo sapiens gene PIK3C2G
Size :
200 reactions
Price US :
142 USD
Delivery Time US :
5 Days
Symbol :
PIK3C2G
Uniprot ID :
O75747
Accn :
NM_001288772 , NM_001288774 , NM_004570 , NM_004570.2 , NM_004570.3 , NM_004570.4 , NM_004570.5 , NM_001288774.1 , NM_001288772.1 , BC130277 , BC144133 , BC144134 , BX092808 , NM_001288772.2
more info or order :
company information

OriGene
9620 Medical Center Dr., Suite 200
Rockville, MD 20850
Rockville, MD 20850
custsupport@origene.com
https://www.origene.com1-888-267-4436
headquarters: USA
OriGene Technologies, Inc. is a gene centric life sciences company dedicated to support biomedical scientists in gene functions and drug discovery. OriGene’s novel product line includes the world’s largest collections of cDNA clones (TrueClone and TrueORF), shRNA (HuSH-29), purified human recombinant proteins, high quality TrueMAB™ monoclonal antibodies to human proteins, 100,000 highly validated human tissues, and qPCR arrays. OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. OriGene is a Luminex Certified Partner™ and offers multiplexed immunoassays and multiplexed assays for a broad range of biomarkers.
related products
browse more products
- PKNOX1 Human qPCR Primer Pair (NM_004571) | HP207865
- Phospholipase C beta 2 (PLCB2) Human qPCR Primer Pair (NM_004573) | HP207866
- SEPTIN4 Human qPCR Primer Pair (NM_004574) | HP207867
- POU4F2 Human qPCR Primer Pair (NM_004575) | HP207868
- Phosphoserine phosphatase (PSPH) Human qPCR Primer Pair (NM_004577) | HP207870
questions and comments